Recurrent hepatitis C after liver transp
โ
Ibrahim A. Hanouneh; Charles Miller; Federico Aucejo; Rocio Lopez; Mary Kay Quin
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 123 KB
๐ 2 views
Sustained virologic response (SVR) in the treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation (LT) remains suboptimal. We evaluated efficacy of pegylated interferon alfa (PEG) and ribavirin (RBV) (PEG/RBV) combination therapy in LT recipients with recurrent HCV and p